SCHEMBL19976854

SCHEMBL19976854

CC(C)CN/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2ccc(C(F)(F)F)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.42
MAP2K4 P45985 3/20 0.42
MAPK1 P28482 2/20 0.42
MAPKAPK3 Q16644 2/20 0.42
MAPK6 Q16659 2/20 0.42
TRPA1 O75762 2/20 0.41
HDAC6 Q9UBN7 1/20 0.40
CCR2 P41597 3/20 0.39
KCNH2 Q12809 2/20 0.39
DYRK1A Q13627 4/20 0.38
MAPK8 P45983 2/20 0.38
MAPK10 P53779 1/20 0.38
FADS1 O60427 1/20 0.38
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
NTRK1 P04629 2/20 0.37
PLK4 O00444 1/20 0.36
MAPK13 O15264 1/20 0.36
DAPK3 O43293 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976767 0.93 GSK3B (0.51) GSK3BMAP2K4MAPK1MAPK6TRPA1
SCHEMBL19976866 0.89 DYRK1A (0.42) GSK3BMAP2K4MAPK1DYRK1AMAPK8
SCHEMBL19976800 0.89 GSK3B (0.43) GSK3BMAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL19976846 0.87 KDM4E (0.42) GSK3BMAPK1HDAC6DYRK1AMAPK8
SCHEMBL19976736 0.86 MAP2K4 (0.44) GSK3BMAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL19976729 0.86 HDAC6 (0.49) GSK3BMAP2K4MAPK1MAPK6TRPA1
SCHEMBL19976815 0.85 GSK3B (0.44) GSK3BMAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL19976789 0.84 GSK3B (0.42) GSK3BMAPK1HDAC6DYRK1ALMNA
SCHEMBL19976762 0.84 MAP2K4 (0.40) GSK3BMAP2K4MAPK1MAPKAPK3MAPK6
SCHEMBL19976776 0.83 GSK3B (0.48) GSK3BMAP2K4MAPK1TRPA1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed